Literature DB >> 26069604

Evolution and Current Role of Autologous Chondrocyte Implantation for Treatment of Articular Cartilage Defects in the Football (Soccer) Player.

Kai Mithoefer1, Lars Peterson2, Daniel B F Saris3, Bert R Mandelbaum4.   

Abstract

BACKGROUND: Autologous chondrocyte implantation (ACI) continues to technically evolve, but how the technical innovations affect the ability to participate in high-impact sports such as football is unknown.
METHODS: Clinical studies describing athletes treated with first-, second-, or third-generation ACI techniques were reviewed. The technical developments of ACI were evaluated, and the results in athletes and specifically football (soccer) players were analyzed.
RESULTS: Football players reported 72% good to excellent results with significant overall improvement of knee function and activity scores. Return to football was 83% in competitive players but lower in recreational players. Eighty percent of players returned to the same competitive level after ACI, and 87% to 100% maintained their ability to play sports at 5 years postoperatively. Return to sport was better for younger, competitive players with shorter intervals between injury and ACI. New developments of the surgical technique and postoperative rehabilitation were able to reduce the limitations associated with first-generation ACI including invasiveness, graft hypertrophy, and particularly long postoperative rehabilitation. This allowed for faster return to sports like football without compromising the ability for continued competition over time.
CONCLUSION: Articular cartilage repair in football players often allows for successful return to this high-impact sport with excellent durability. The continued evolution of this technique has improved initial shortcomings with important implications for both the professional and recreational athlete.

Entities:  

Keywords:  articular cartilage < tissue; autologous chondrocyte < grafts; cartilage repair < repair; knee < joint involved; sports injury < diagnosis

Year:  2012        PMID: 26069604      PMCID: PMC4297163          DOI: 10.1177/1947603511406532

Source DB:  PubMed          Journal:  Cartilage        ISSN: 1947-6035            Impact factor:   4.634


Introduction

Articular cartilage injuries have been observed with increasing frequency in collegiate, professional, and world-class football players and may be associated with the increased rate of joint degeneration and disability in the football population.[1-6] To assure continued sports activity without risking joint degeneration and long-term disability, durable articular cartilage resurfacing is critically relevant for the football athlete with articular cartilage injury. Successful repair of articular cartilage lesions of the human knee by autologous chondrocyte implantation (ACI) was first reported by Brittberg in 1994[7] and has demonstrated excellent results after up to 20 years in the general population.[7,8] Because of the relative invasiveness of the first-generation technique, its long rehabilitation time, and complications resulting from the use of periosteum, researchers have aimed to reduce these limitations through continued improvement and development of this technique and its postoperative rehabilitation. This article provides an overview of the gradual evolution of ACI since its first introduction and describes how these innovations may affect postoperative sports participation in football players with articular cartilage defects.

Technical Evolution of ACI

First-Generation Technique

With this original ACI technique, cartilage harvesting was performed in a primary procedure, followed by cell isolation and expansion in vitro. Implantation of the cultured chondrocytes was then performed in a second open procedure under a periosteal patch acquired from the proximal tibia and sutured to the surrounding stable cartilage margins with the cambium layer facing toward the defect.[7] The periosteal rim was sealed with fibrin glue, and the cultured chondrocytes were then injected under the periosteal flap covering the articular cartilage defect. This procedure often required a large incision for access to the defect and periosteal harvest (). The results of this first-generation technique have been described specifically for football players.[9] Good and excellent results were reported in 72% overall, in 85% of players with single cartilage lesions, and in 93% of single defects located on the medial femoral condyle. Postoperative Tegner activity scores improved in 82% from an average 3.6 ± 0.2 points preoperatively to 6.1 ± 0.5 points at last follow-up (P < 0.001). While overall rate to return to football was 33%, return rate was significantly better for competitive players at 83% compared to 16% in recreational players (P < 0.001). Best return rates were observed in adolescent athletes with a return rate of 96%.[10] Eighty percent of returning players returned to the preinjury skill level. Average time to return to football was 18 months (range, 12-24 months) for first-generation ACI. Time to return was shorter in high-level soccer players (14 months) than in recreational players (22 months) (P < 0.001). Of the returning players, 87% continued to play 52 months after ACI.
Figure 1.

Intraoperative image of a football player treated with first-generation autologous chondrocyte implantation, demonstrating a full arthrotomy and sutured periosteal patch.

Intraoperative image of a football player treated with first-generation autologous chondrocyte implantation, demonstrating a full arthrotomy and sutured periosteal patch. Return to football was significantly better in players with single cartilage lesions of the femur, younger age (≤25 years), and players who underwent ACI early (<12 months after injury). In fact, the ability to return to playing football was 4 times higher when ACI was performed within 1 year after injury (Table 1). No significant association was found between return to football and gender, defect type, defect location, defect size, or number of prior surgeries. Concomitant procedures such as ligament reconstructions or osteotomies did not decrease the ability to return to football, as 56% of players with osteotomies were able to return to play football. Interestingly, postoperative participation in athletic activities improved the long-term functional results after first-generation ACI.[11] The failure rate was 13%, with half of the failures resulting from traumatic delamination of hypertrophic grafts.
Table 1.

Factors Affecting Return to Play after Autologous Chondrocyte Implantation

FactorBetter/faster return to play
AgeAge <25 y
Preoperative intervalDuration <12 mo
Athletic skill levelCompetitive athletes
Adjuvant proceduresSimultaneous surgery
Surgical invasivenessMinimally invasive procedure
RehabilitationIndividualized sport-specific rehabilitation
Factors Affecting Return to Play after Autologous Chondrocyte Implantation

Characterized Chondrocyte Implantation

The in vitro culture and expansion of human chondrocytes for ACI have been shown to result in a dedifferentiation of the cultured cells with a shift from a predominantly type II collagen-containing hyaline matrix to a fibrocartilage-like type I collagen-rich repair cartilage.[12,13] To address this aspect, characterized chondrocyte implantation (CCI) has been developed to improve hyaline articular cartilage regeneration through the identification and selective expansion of specific chondrocyte subpopulations capable of producing more hyaline-like repair cartilage tissue. CCI uses the first-generation ACI surgical technique with a periosteal patch. Prospective, randomized, controlled clinical comparison of CCI with microfracture has shown superior structural repair and histomorphometry with CCI at 12 months.[12] Clinical results at 36 months have shown significantly increased Knee injury and Osteoarthritis Outcome Score (KOOS) sports and recreation subscores that were higher than after microfracture.[13] Better KOOS sports subscores were seen when surgery was performed within 3 years from injury. Recently discussed results show a persistent good outcome at 5 years, and prospective cohort data using CCI with a synthetic membrane clearly demonstrate a reduction of hypertrophy compared to periosteal coverage.[14] The same authors found significant increases of the Activity Rating Scale after CCI and that low-level joint-loading activities after surgery had a beneficial effect on postoperative recovery with both faster return to preinjury activity levels and significantly better overall knee function. Graft hypertrophy was observed in 25% after CCI, with a failure rate of 4% at 36 months.[13,15]

Second-Generation Techniques

To avoid the frequent complication of graft hypertrophy and the associated risk from delamination or requirement for surgical chondroplasty of the hypertropic graft, bioabsorbable collagen membrane was developed as an innovative temporary cover of the treated defect instead of the autologous periosteal patch. This so-called collagen-covered ACI (CACI) had the advantage of reducing the invasiveness of the procedure; however, it still required an arthrotomy and suturing of the collagen membrane into the defect (). Clinical results were similar to first-generation ACI, but this technique was able to reduce the incidence of graft hypertrophy to 6%.[16]
Figure 2.

Intraoperative image of collagen membrane autologous chondrocyte implantation (CACI) using mini-arthrotomy and suture fixation of the collagen membrane.

Intraoperative image of collagen membrane autologous chondrocyte implantation (CACI) using mini-arthrotomy and suture fixation of the collagen membrane.

Third-Generation Techniques

The so-called third-generation ACI techniques use biodegradable membranes or scaffolds to temporarily support the chondrocytes until they are replaced by neocartilage matrix components synthesized from the implanted cells. These techniques involve attachment or “seeding” of the cultured chondrocytes into type I/III collagen membranes or 3-dimensional scaffolds and avoid the need for the periosteum. Scaffolds and membranes can be based on carbohydrates (polylactic/polyglycolic acid, hyaluronan, agarose, alginate), protein polymers (collagen, fibrin, gelatin), artificial polymers (carbon fiber, hydroxyapatite, Teflon, polybutyric acid), or composite polymer matrices. Matrix-induced ACI (MACI) uses a biomatrix seeded with chondrocytes and further reduces surgical invasiveness, perioperative morbidity, and risk for complications such as scarring and arthrofibrosis[17] (). It also has the theoretical advantages of less chondrocyte leakage and more homogeneous chondrocyte distribution. This technique can be performed through a mini-arthrotomy using fibrin glue for fixation of the cell-seeded membrane into the defect. Clinical results have shown significant increases in KOOS sports and recreation subscores and Tegner activity scores at 2-year follow-up.[17,18] Specific information on return to sport in the athletic population or football players is not available. The MACI technique has been associated with a reduction of graft hypertrophy to 7%.[16] Biopsy at 12 months showed evidence of hyaline-like tissue, and magnetic resonance imaging (MRI) showed good defect filling. Arthroscopic MACI has been described with a hyaluronic acid–based scaffold and showed significant improvement of knee function in 90% of the athletic population after 5 years[19,20] (). Significant improvement of Tegner activity scores was observed during the first 2 years, with 100% durability of the functional improvement until 5 years after implantation. The athlete’s age significantly correlated with the ability to resume sports activity. Concomitant procedures like anterior cruciate ligament (ACL) reconstruction were associated with the same incidence and durability of the functional improvement and same rate of resumption of sports activity. The graft hypertrophy rate was the lowest with the arthroscopic technique, with a reported rate of 4%, but the rate of delamination has not been reported.
Figure 3.

Intraoperative image of matrix-induced autologous chondrocyte implantation (MACI) using a minimally invasive technique with fibrin glue fixation of the chondrocyte-seeded matrix.

Figure 4.

Intraoperative image of arthroscopic autologous chondrocyte implantation using a 3-dimensional hyaluronic acid scaffold seeded with chondrocytes covering the cartilage defect. From Kon et al.[19]

Intraoperative image of matrix-induced autologous chondrocyte implantation (MACI) using a minimally invasive technique with fibrin glue fixation of the chondrocyte-seeded matrix. Intraoperative image of arthroscopic autologous chondrocyte implantation using a 3-dimensional hyaluronic acid scaffold seeded with chondrocytes covering the cartilage defect. From Kon et al.[19]

Advances in ACI Rehabilitation

Postoperative rehabilitation has traditionally been prolonged long after chondrocyte implantation with empirically based duration of joint protection and load progression following the biological phases of cartilage healing and maturation.[21] While early rehabilitation protocols have focused on protection, more recent evidence has demonstrated that accelerated rehabilitation with early limited loading improves cartilage healing, knee function, and sports participation after chondrocyte implantation.[11,22,23] Decreased invasiveness of the newer-generation ACI allowed for faster postoperative joint mobilization, accelerated neuromuscular recovery, and restoration of joint biomechanics. The addition of individualized rehabilitation programs with stepwise on-field rehabilitation and reintegration into the sport-specific movement and joint loading patterns has been successful in reducing the average time to return to sport from 18 months with the first-generation ACI technique to an average of 11 months with the arthroscopic third-generation technique without compromising the return rate or durability even in highly competitive players.[22]

Discussion

ACI has been described as a successful technique for the restoration of full-thickness articular cartilage lesions in the knee by several investigators.[7,8,16] Recent data indicate excellent long-term durability of articular cartilage restoration and improved knee function up to 20 years postoperatively.[8] This technique has been successfully used for articular cartilage repair in athletes and specifically football players.[9] The good results in this population are encouraging because articular cartilage injuries are frequent in football players and often associated with the limited ability to play and increased risk for the development of knee osteoarthritis in this high-demand athletic population, particularly at the elite level.[1,4,6,24] The increased injury rate in football players results from the high joint stresses associated with the repetitive joint impact and torsional loading seen with rapid deceleration motions, frequent pivoting, and player contact in football as well as the high incidence of ACL and meniscus injuries in this sport. The fact that chondrocyte transplantation in this population provides lasting functional improvement and return to football demonstrates the ability of the repair cartilage tissue to withstand even maximum mechanical stress over time in vivo. Because injuries to the articular cartilage of the knee have been shown to present one of the most common causes of permanent disability in soccer players,[1,3,25] successful treatment of cartilage defects may be able to reduce the likelihood of important long-term joint dysfunction and associated loss of sports participation in this population.[6,24] The percentage of good to excellent results observed after ACI in football players falls within the previously reported range of good to excellent results reported with this technique.[8,16,26] Similar to the results in the mixed populations of previous studies, isolated lesions of the femoral condyle in the football population were associated with better outcomes. Significant improvement of activity scores was observed in more than 80% of players, confirming the overall functional improvements described after autologous chondrocytes in previous studies.[8,15,26] The return rate was significantly higher in high-level competitive athletes than in recreational-level players. This phenomenon is also observed for other cartilage repair techniques or ACL reconstruction[1,2,11,27] and can be attributed to the higher portion of acute lesions, younger age, and differences in postoperative rehabilitation, chronic deconditioning, and absence from competition. Higher motivation, fear of reinjury, and economic and social aspects will also influence the difference between the return to sport in recreational and professional athletes.[28] Return to football is significantly better if cartilage repair is performed within 12 months after injury.[8-10] Delayed surgery has been associated with significantly inferior repair cartilage morphology,[27] which may result from the development of degenerative joint changes if the defect is left untreated for too long. Experimental studies have shown a change in joint hemostasis with increased glycosaminoglycan loss with delayed repair and significantly better repair cartilage quality with early repair.[29] Early surgical treatment of articular cartilage lesions is therefore recommended to optimize postoperative joint function and sports activity. Player age affected the ability to return to football after chondrocyte transplantation and was also observed with other cartilage repair techniques.[30] This effect can be attributed to the decreasing metabolic activity of chondrocytes with increasing age as well as change in social demands. Average time to return to football was 18 months after first-generation techniques. Newer second- and third-generation implantation techniques combined with accelerated and sport-specific rehabilitation have allowed a marked reduction of the time to return to sport to an average of 11 months.[22] Limited invasiveness of the newer implantation techniques leads to less surgical trauma to the joint with reduced disruption of joint motion, mechanoreceptors, and muscular inhibition, thereby accelerating recovery of the functional joint unit and optimizing the environment for graft stimulation and maturation. Improved understanding of the graft maturation process and the effect of gradual early graft loading has been one important aspect of this improvement.[21-23] Importantly, chondrocyte implantation has shown the best durability of all cartilage repair techniques after return to sport, as 87% of returning players were still competing at a mean of 52 months postoperatively.[31] This may be because of the improved histological tissue quality seen with this technique compared to other techniques.[12,13] While initial recovery with chondrocyte transplantation may be more prolonged, our data suggest that this cartilage repair technique provides excellent durability even under very high athletic demands. Some world-class players were able to rapidly return to their preinjury level of play with excellent long-term durability of more than 9 years in professional football. In contrast to other cartilage repair procedures, this positive effect does not seem to be limited to small defect size or primary cartilage repair but is equally successful in large defects and revision situations.[31,32] Hypertrophy of the grafted periosteum has been described in up to 26% in first-generation ACI[8,16] and was associated with an increased rate of traumatic delamination particularly in high-impact pivoting sports like football.[9] Technical modifications such as CACI and MACI have successfully reduced the rate of graft hypertrophy to 4% to 7%.[16,17,33] This reduced risk likely translates into a decreased risk for traumatic delamination in athletes and facilitates more rapid activity progression and return to sport. Concomitant injuries such as ligamentous instability are frequently associated with articular cartilage lesions. Addressing concomitant pathologies has been shown to improve cartilage repair and does not negatively influence the ability to return to sport.[8,9,31] By performing all repair procedures simultaneously, repeated surgical intervention with prolonged rehabilitation and absence from competition can be avoided, and return to sport becomes more likely. In summary, ACI has gone through a significant evolution since its first description in 1994. The first-generation technique demonstrated the efficacy of this cartilage repair procedure to return athletes to demanding sports such as football with excellent durability. Young, competitive players who undergo surgery within 12 months after injury will have the highest chance of returning to sports activity. While the initial ACI technique was associated with several limitations because of invasiveness, frequent graft hypertrophy, and long intervals until return to competition, stepwise improvements of the surgical technique and rehabilitation have successfully addressed these shortcomings with reduced morbidity, complication rate, and accelerated return to sport without compromising the return rate or ability to compete over time.
  32 in total

Review 1.  Autologous chondrocyte implantation postoperative care and rehabilitation: science and practice.

Authors:  Karen Hambly; Vladimir Bobic; Barbara Wondrasch; Dieter Van Assche; Stefan Marlovits
Journal:  Am J Sports Med       Date:  2006-01-25       Impact factor: 6.202

2.  Autologous chondrocyte implantation in the knee joint: open compared with arthroscopic technique. Comparison at a minimum follow-up of five years.

Authors:  Alberto Ferruzzi; Roberto Buda; Cesare Faldini; Francesca Vannini; Francesco Di Caprio; Deianira Luciani; Sandro Giannini
Journal:  J Bone Joint Surg Am       Date:  2008-11       Impact factor: 5.284

Review 3.  Are there long-term sequelae from soccer?

Authors:  H Roos
Journal:  Clin Sports Med       Date:  1998-10       Impact factor: 2.182

4.  Functional outcome of knee articular cartilage repair in adolescent athletes.

Authors:  Kai Mithöfer; Tom Minas; Lars Peterson; Howard Yeon; Lyle J Micheli
Journal:  Am J Sports Med       Date:  2005-07-06       Impact factor: 6.202

5.  Articular cartilage repair in soccer players with autologous chondrocyte transplantation: functional outcome and return to competition.

Authors:  Kai Mithöfer; Lars Peterson; Bert R Mandelbaum; Tom Minas
Journal:  Am J Sports Med       Date:  2005-08-10       Impact factor: 6.202

6.  Propensity for osteoarthritis and lower limb joint pain in retired professional soccer players.

Authors:  S Drawer; C W Fuller
Journal:  Br J Sports Med       Date:  2001-12       Impact factor: 13.800

7.  Epidemiology of anterior cruciate ligament injuries in soccer.

Authors:  J M Bjordal; F Arnły; B Hannestad; T Strand
Journal:  Am J Sports Med       Date:  1997 May-Jun       Impact factor: 6.202

Review 8.  Cell carriers as the next generation of cell therapy for cartilage repair: a review of the matrix-induced autologous chondrocyte implantation procedure.

Authors:  Mats Brittberg
Journal:  Am J Sports Med       Date:  2009-12-04       Impact factor: 6.202

Review 9.  Osteoarthritis: new insights. Part 1: the disease and its risk factors.

Authors:  D T Felson; R C Lawrence; P A Dieppe; R Hirsch; C G Helmick; J M Jordan; R S Kington; N E Lane; M C Nevitt; Y Zhang; M Sowers; T McAlindon; T D Spector; A R Poole; S Z Yanovski; G Ateshian; L Sharma; J A Buckwalter; K D Brandt; J F Fries
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

10.  Treatment of articular cartilage defects in athletes: an analysis of functional outcome and lesion appearance.

Authors:  F T Blevins; J R Steadman; J J Rodrigo; J Silliman
Journal:  Orthopedics       Date:  1998-07       Impact factor: 1.390

View more
  7 in total

Review 1.  Management of knee articular cartilage injuries in athletes: chondroprotection, chondrofacilitation, and resurfacing.

Authors:  Iain R Murray; Michael T Benke; Bert R Mandelbaum
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-02-07       Impact factor: 4.342

2.  Osteoarthritis in Football.

Authors:  Gian M Salzmann; Stefan Preiss; Marcy Zenobi-Wong; Laurent P Harder; Dirk Maier; Jirí Dvorák
Journal:  Cartilage       Date:  2016-07-08       Impact factor: 4.634

3.  Cartilage Repair by Mesenchymal Stem Cell-Derived Exosomes: Preclinical and Clinical Trial Update and Perspectives.

Authors:  Shahrbano Jahangir; Mojtaba Khozaei Ravari; Leila Taghiyar; Mohammad Amin Shamekhi; Mohamadreza Baghaban Eslaminejad
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Cartilage issues in football-today's problems and tomorrow's solutions.

Authors:  Kai Mithoefer; Lars Peterson; Marcy Zenobi-Wong; Bert R Mandelbaum
Journal:  Br J Sports Med       Date:  2015-05       Impact factor: 13.800

5.  Cartilage Issues in Football (Soccer): An Executive Summary of the Fédération Internationale de Football Association (FIFA)/ International Cartilage Repair Society (ICRS) Initiative.

Authors:  Bert Mandelbaum; Kai Mithoefer; Lars Peterson; Daniel Saris; Jiri Dvorák
Journal:  Cartilage       Date:  2012-01       Impact factor: 4.634

6.  A conceptual framework for a sports knee injury performance profile (SKIPP) and return to activity criteria (RTAC).

Authors:  David Logerstedt; Amelia Arundale; Andrew Lynch; Lynn Snyder-Mackler
Journal:  Braz J Phys Ther       Date:  2015-10-06       Impact factor: 3.377

7.  Survival Rates of Various Autologous Chondrocyte Grafts and Concomitant Procedures. A Prospective Single-Center Study over 18 Years.

Authors:  David Martinčič; Jakob Mekač; Matej Drobnič
Journal:  Cell Transplant       Date:  2019-08-02       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.